Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Research Highlight Published: GLP-1 receptor agonism Nature Aging volume 6 , pages 2728 (2026) Cite this article 729 Accesses 1 Citations 2 Altmetric Metrics details Regarding the recently announced failure of a GLP-1RA trial in clinical stage Alzheimers disease, we believe this highlights the need for a strategic shift, not an abandonment of the drug class in neurodegeneration, says Ho Ko, co-corresponding author of the study
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, et al
With nearly a third of employees willing to change jobs over this benefit, GLP-1 coverage is no longer a clinical decision delegated to the benefits team
We started the adjunctive therapies program at Breakthrough T1D because this was not just the right thing to do, it was required, Dutta said
